Study identifies new potential treatment option for triple negative breast cancer
In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is ...
May 21, 2018
0
730